Anti-EST3/ CES3/ ES31 functional antibody

Anti-EST3/ CES3/ ES31 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CES3/CES3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1602-Ab-1/ GM-Tg-hg-SE1602-Ab-2Anti-Human CES3 monoclonal antibodyHuman
GM-Tg-rg-SE1602-Ab-1/ GM-Tg-rg-SE1602-Ab-2Anti-Rat CES3 monoclonal antibodyRat
GM-Tg-mg-SE1602-Ab-1/ GM-Tg-mg-SE1602-Ab-2Anti-Mouse CES3 monoclonal antibodyMouse
GM-Tg-cynog-SE1602-Ab-1/ GM-Tg-cynog-SE1602-Ab-2Anti-Cynomolgus/ Rhesus macaque CES3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1602-Ab-1/ GM-Tg-felg-SE1602-Ab-2Anti-Feline CES3 monoclonal antibodyFeline
GM-Tg-cang-SE1602-Ab-1/ GM-Tg-cang-SE1602-Ab-2Anti-Canine CES3 monoclonal antibodyCanine
GM-Tg-bovg-SE1602-Ab-1/ GM-Tg-bovg-SE1602-Ab-2Anti-Bovine CES3 monoclonal antibodyBovine
GM-Tg-equg-SE1602-Ab-1/ GM-Tg-equg-SE1602-Ab-2Anti-Equine CES3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1602-Ab-1/ GM-Tg-hg-SE1602-Ab-2; GM-Tg-rg-SE1602-Ab-1/ GM-Tg-rg-SE1602-Ab-2;
GM-Tg-mg-SE1602-Ab-1/ GM-Tg-mg-SE1602-Ab-2; GM-Tg-cynog-SE1602-Ab-1/ GM-Tg-cynog-SE1602-Ab-2;
GM-Tg-felg-SE1602-Ab-1/ GM-Tg-felg-SE1602-Ab-2; GM-Tg-cang-SE1602-Ab-1/ GM-Tg-cang-SE1602-Ab-2;
GM-Tg-bovg-SE1602-Ab-1/ GM-Tg-bovg-SE1602-Ab-2; GM-Tg-equg-SE1602-Ab-1/ GM-Tg-equg-SE1602-Ab-2
Products NameAnti-CES3 monoclonal antibody
Formatmab
Target NameCES3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CES3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1602-Ag-1Recombinant multi-species EST3/ CES3/ ES31 protein


    Target information

    Target IDGM-SE1602
    Target NameCES3
    Gene ID23491,13909,689754,101097032,513112
    Gene Symbol and SynonymsCES3,Ces3-ps1,Ces31L,Ces3a,Ces3b,Ces3L,EG13909,ES31,ES31L,Gm4738
    Uniprot AccessionQ6UWW8
    Uniprot Entry NameEST3_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000172828
    Target ClassificationN/A

    The target: CES3, gene name: CES3, also named as ES31. This gene encodes a member of the carboxylesterase large family. The family members are responsible for the hydrolysis or transesterification of various xenobiotics, such as cocaine and heroin, and endogenous substrates with ester, thioester, or amide bonds. They may participate in fatty acyl and cholesterol ester metabolism, and may play a role in the blood-brain barrier system. This gene is expressed in several tissues, particularly in colon, trachea and in brain, and the protein participates in colon and neural drug metabolism. Multiple alternatively spliced transcript variants encoding distinct isoforms have been reported, but the biological validity and/or full-length nature of some variants have not been determined.[provided by RefSeq, Jun 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.